Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4100
+0.0092 (2.30%)
Mar 3, 2026, 4:00 PM EST - Market closed
Impact BioMedical Employees
Impact BioMedical had 2 employees as of December 31, 2024. The number of employees increased by 1 or 100.00% compared to the previous year.
Employees
2
Change (1Y)
1
Growth (1Y)
100.00%
Revenue / Employee
$12,500
Profits / Employee
-$22,095,500
Market Cap
42.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 2 | 1 | 100.00% |
| Dec 31, 2023 | 1 | -1 | -50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Acrivon Therapeutics | 78 |
| Aligos Therapeutics | 70 |
| Kezar Life Sciences | 55 |
| NextCure | 43 |
| MiNK Therapeutics | 23 |
| Veru Inc. | 20 |
| Apollomics | 13 |
| Telomir Pharmaceuticals | 9 |
IBO News
- 7 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 9 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 1 year ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire